Development of oral controlled-tablet formulations based on diltiazem-carrageenan complex

Pharmaceutical Development and Technology

Volumn 9, Issue 2, 2004, Pages 155-162

  Bonferoni, M C ^a   Rossi, S ^a   Ferrari, F ^a   Caramella, C ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Controlled release; Diltiazem HCl; Drug polymer complex; Lambda carrageenan

Indexed keywords

CARRAGEENAN; DILTIAZEM; HYDROXYPROPYLMETHYLCELLULOSE; POVIDONE; WATER;

ARTICLE; COMPRESSIVE STRENGTH; CONTROLLED RELEASE FORMULATION; DRUG RELEASE; PARTICLE SIZE; PH; PRIORITY JOURNAL; SURFACE PROPERTY; TABLET COMPRESSION;

ADMINISTRATION, ORAL; CARRAGEENAN; COMPRESSIVE STRENGTH; DELAYED-ACTION PREPARATIONS; DILTIAZEM; DRUG COMPOUNDING; EXCIPIENTS; HYDROGEN-ION CONCENTRATION; SOLUBILITY; TABLETS; TIME FACTORS;

EID: 2942750189     PISSN: 10837450     EISSN: None     Source Type: Journal    
DOI: 10.1081/PDT-120027428     Document Type: Article

References (24)

1. Feely, L.C.; Davis, S.S. The influence of polymeric excipients on drug release from hydroxypropylmethylcellulose matrices. Int. J. Pharm. 1988, 44, 131-139.
2. Graham, D.H.; Baker, Y.M. Interaction of antihistamines with hydrocolloids. J. Pharm. Sci. 1963, 52, 964-967.
3. Takka, S.; Rajabhandari, S.; Sakr, A. Effect of anionic polymers on the release of propranolol hydrochloride from matrix tablets. Eur. J. Pharm. Biopharm. 2001, 52, 75-82.
4. Bonferoni, M.C.; Rossi, S.; Tamayo, M.; Pedraz, J.L.; Dominguez Gil, A.; Caramella, C. On the employment of lambda carrageenan in a matrix system. II. Lambda carrageenan and hydroxypropylmethylcellulose mixtures. J. Control. Release 1994, 30, 175-182.
5. Handbook of Water Soluble Gums and Resins; Davidsons, R. L., Ed.; McGraw-Hill, 1980.
6. Picker, K.M. Matrix tablets of carrageenans. Release behaviour and effect of added cations. Drug Dev. Ind. Pharm. 1999, 25 (3), 339-346.
7. Picker, K.M. The use of carrageenan in mixture with microcristalline cellulose and its functionality for making tablets. Eur. J. Pharm. Biopharm. 1999, 48, 27-36.
8. Hariharan, M.; Wheatley, T.A.; Price, J.C. Controlled-release tablet matrices from carrageenan: compression and dissolution studies. Pharm. Dev. Technol. 1997, 2 (4), 383-393.
9. Hariharan, M.; Gupta, V.; Price, J.C. Optimization of sustained-release tablet formulations: a four-component mixture experiment. Pharm. Dev. Technol. 1997, 2 (4), 365-371.
10. Verschueren, E.; Van Santvliet, L.; Ludwig, A. Evaluation of various carrageenans as ophthalmic viscolysers. STP Pharma Sci. 1995, 6, 203-210.
11. Bonferoni, M.C.; Chetoni, P.; Rossi, S.; Ferrari, F.; Helle, M.I.; Caramella, C. In Timolol Maleate Ophthalmic Formulations Based on Carrageenan-Gelatin Mixtures: In Vitro and Preliminary In Vivo Studies, 20th Pharm. Technol. Conference, Liverpool, April 24-26, 2001.
12. Bonferoni, M.C.; Rossi, S.; Tamayo, M.; Pedraz, J.L.; Dominguez Gil, A.; Caramella, C. On the employment of lambda carrageenan in a matrix system. I. Sensitivity to dissolution medium and comparison with Na carboxymethylcellulose and xanthan gum. J. Control. Release 1993, 26, 119-127.
13. Bonferoni, M.C.; Rossi, S.; Ferrari, F.; Bertoni, M.; Bolhuis, G.K.; Caramella, C. On the employment of lambda (carrageenan in a matrix system. III. Optimization of a lambda carrageenan-HPMC hydrophilic matrix. J. Control. Release 1998, 51, 231-239.
14. Gupta, V.K.; Hariharan, M.; Wheatley, T.A.; Price, J.C. Controlled-release tablets from carrageenans: effect of formulation, storage and dissolution factors. Eur. J. Pharm. Biopharm. 2001, 51, 241-248.
15. Nujoma, Y.N.; Kim, C. A designer's polymer as an oral drug carrier (tablet) with pseudo-zero-order release kinetics. J. Pharm. Sci. 1996, 85, 1091-1095.
16. Konar, N.; Kim, C. Drug release from drug-polyanion complex tablets: poly (acrylamido-2-methyl-1-propanesulfonate sodium-co-methyl methacrylate). J. Control. Release 1999, 57, 141-150.
17. Aguzzi, C.; Bonferoni, M.C.; Osorio Fortich, M.R.; Rossi, S.; Ferrari, F.; Caramella, C. Influence of complex solubility on formulations based on lambda carrageenan and basic drugs. AAPS PharmSciTech 2002, 3 (3), article 27. (http://www.aapspharmsci.org).
18. Bonferoni, M.C.; Rossi, S.; Ferrari, F.; Bettinetti, G.P.; Caramella, C. Characterization of a diltiazem-lambda carrageenan complex. Int. J. Pharm. 2000, 200, 207-216.
19. Bonferoni, M.C.; Rossi, S.; Ferrari, F.; Stavik, E.; Pena Romero, A.; Caramella, C. Factorial analysis of the influence of dissolution medium on drug release from carrageenan-diltiazem complexes. AAPS PharmSciTech 2000, 1 (2), article 15. (http://www.aapspharmsci.org).
20. Martindale. The Extra Pharmacopea, 29th Ed.; J.E.F. Reynolds, Ed.; The Pharmaceutical Press: London, 1989.
21. Kim, H.; Fassihi, R. A new ternary polymeric matrix system for controlled drug delivery of highly soluble drugs: I. diltiazem hydrochloride. Pharm. Res. 1997, 14, 1415-1421.
22. Caramella, C.M., Bonferoni, M.C. Complex Between Carrageenan and a Water Soluble Drug Having a Specific Granulometry and Relative Controlled Release Pharmaceutical Compositions. U.S. Patent 6,355,272, March 12, 2002.
23. Edmunson, I.C. Particle size analysis. Adv. Pharm. Sci. 1967, 2, 95-179.
24. Ritger, P.L.; Peppas, N.A. A simple equation for description of solute release. I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or disks. J. Control. Release 1987, 5, 23-26.